Navigation Links
Simcere Pharmaceutical Group Announces Sale of Equity Interest in Boda
Date:6/24/2013

NANJING, China, June 24, 2013 /PRNewswire/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today announced that it entered into a share transfer agreement with Zhuhai Rongding Equity Investment Partnership L.P. on June 17, 2013 to sell Simcere's approximately 99.99% equity interest in Jilin Boda pharmaceutical Co., Ltd. ("Boda"), which is currently the manufacturer of Yidasheng, for a cash consideration of RMB400 million.

Simcere holds an approximately 99.99% stake in Boda through acquisitions made since 2007. Upon completion of this transaction, Simcere will no longer hold any equity interest in Boda. Consummation of the transaction is subject to certain closing conditions. 

About Simcere Pharmaceutical Group

Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR) is a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China. Simcere concentrates its research and development efforts on the treatment of diseases with high incidence and/or mortality rates and for which there is a clear demand for more effective pharmacotherapy such as cancer, strokes, cardiovascular disease, infectious diseases and pain. For more information about Simcere Pharmaceutical Group, please visit www.simcere.com.

Investor and Media Contacts:

Email: ir@simcere.com

In Nanjing:

Jie Liu D'Elia

Vice President

Simcere Pharmaceutical Group

Tel: 86-25-8556-6666*8857

In the United States:

Cindy Zheng

Brunswick Group LLC

Tel: 1-212-333-3810

 



In Beijing:

Yue Yu

Brunswick Group

Tel: 86-10-5960-8600



'/>"/>
SOURCE Simcere Pharmaceutical Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Bristol-Myers Squibb and Simcere Enter Partnership to Co-Develop and Co-Commercialize Orencia(R) SC (abatacept) in China
2. Simcere Pharmaceutical Group Announces Resignation of Chief Scientific Officer
3. Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2013 Results
4. Simcere Pharmaceutical Group Filed 2012 Annual Report on Form 20-F
5. Simcere Pharmaceutical Group to Announce First Quarter 2013 Financial Results on Thursday, May 9, 2013
6. Simcere Pharmaceutical Group Announces its Special Committees Engagement of Financial Advisor
7. Simcere Pharmaceutical Group Announces Issuance of GMP Certificate to Simcere Vaxtec
8. Simcere Pharmaceutical Group Announces its Special Committees Engagement of Legal Counsel
9. Simcere Pharmaceutical Group Announces Receipt of "Going Private" Proposal
10. Simcere Pharmaceutical Group Reports Preliminary Unaudited Fourth Quarter And Full Year 2012 Results
11. Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2012 Financial Results on Thursday, March 7, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/15/2019)... , ... October 14, 2019 ... ... LP2 linearity and calibration verification kit, for Roche cobas® analyzers, Order No. ... Apolipoprotein B (Apo-B). Each VALIDATE® LP2 kit, liquid, ready-to-use, and prepared ...
(Date:10/15/2019)... ... October 14, 2019 , ... An October 4 article on ... correlation between tooth loss and heart disease. The researchers found that individuals between 40 ... of also having heart-related problems, compared to just seven percent for those who never ...
(Date:10/11/2019)... ... October 11, 2019 , ... ... 13, 2019, to recognize the dedication, compassion and quality patient outcomes achieved by ... providing a unique and vital link between patients, providers and payers to improve ...
Breaking Medicine Technology:
(Date:10/10/2019)... ... , ... AltMed Florida , one of the fastest growing Medical Marijuana ... opening of its second MÜV™ Medical Cannabis Dispensary on the First Coast – scheduled ... Beach. , Located at Beach Plaza Shopping Center at the corner of Beach Boulevard ...
(Date:10/8/2019)... ... 2019 , ... Safe Harvest soups in glass jars launch ... Roundy’s, Smiths and Dillons. , Safe Harvest reinvented classic soup recipes to make ... fresh taste is paramount for us,” says Bryan Boches, co-founder of Safe Catch. ...
(Date:10/8/2019)... , ... October 08, 2019 , ... Dr. Amir HagShenas ... in San Jose, CA experience relief from this common and treatable condition. Dr. HagShenas’ ... to save adults from living with uncomfortable symptoms, including tender and bleeding gums, and ...
(Date:10/8/2019)... ... October 08, 2019 , ... PotentiaMetrics, an Austin, TX based ... Chief Medical Officer. Dr. Henderson will be responsible for the development and management ... served as Chair of both the Informatics Governance and the Inpatient Clinical Informatics ...
(Date:10/8/2019)... ... ... Smile Brands Inc. has been named one of the happiest companies in the ... support organization with nearly 440 affiliated practices across 18 states, has a deeply rooted ... is the latest in a series of accolades the company has received ...
Breaking Medicine News(10 mins):